Anti-amyloidogenic effect of AA3E2 attenuates β-amyloid induced toxicity in SK-N-MC cells

Chemico-Biological Interactions

Volumn 186, Issue 1, 2010, Pages 16-23

  Shaykhalishahi, Hamed ^a   Taghizadeh, Mohammad ^a   Yazdanparast, Razieh ^a   Chang, Young Tae ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

A 1 42 fibril; AA3E2; Alzheimer's disease; Anti amyloidogenic; Docking

Indexed keywords

AA 3E 2; AMYLOID BETA PROTEIN[1-42]; CASPASE 3; N [2 (2 (2 AMINOETHOXY)ETHOXY)ETHYL] Q4 N BUTYL 6 DECYL 1,3,5 TRIAZINE 2,4 DIAMINE; REACTIVE OXYGEN METABOLITE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; MOLECULAR DOCKING; NEUROTOXICITY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; L-LACTATE DEHYDROGENASE; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; TRIAZINES;

EID: 77952956345     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.03.042     Document Type: Article

References (42)

1. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimer's Dement 2009, 5:234-270.
2. Katzman R. Epidemiology of Alzheimer's disease. Neurobiol. Aging 2000, 271:18295-18298.
3. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 1997, 20:154-159.
4. Nunam J., Small D.H. Regulation of APP cleavage by alpha-beta- and gamma-secretases. FEBS Lett. 2007, 483:6-10.
5. Findeis M.A. The role of amyloid beta peptide 42 in Alzheimer's disease. Pharmacol. Ther. 2007, 116:266-286.
6. Pimplikar S.W. Reassessing the amyloid cascade hypothesis of Alzheimer's disease. Int. J. Biochem. Cell Biol. 2008, 41:1261-1268.
7. Tjernberg L.O., Callaway D., Tjernberg A., Hahne S., Lilliehook C., Terenius L., et al. A molecular model of Alzheimer's amyloid β-peptide fibril formation. J. Chem. Biol. 1999, 274:12619-12625.
8. Tjernberg L.O., Naslund J., Lindqvist F., Johansson J., Karlstrom A.R., Thyberg J., et al. Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Mol. Biol. 1996, 271:8545-8548.
9. Adessi C., Frossard M.J., Boissard C., Fraga S., Bieler S., Ruckle T., et al. Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. J. Biol. Chem. 2003, 278:13905-13911.
10. Hirohata M., Hasegawa K., Tsutsumi-Yasuhara S., Ohhashi Y., Ookoshi T., Ono K., et al. The anti-amyloidogenic effect is exerted against Alzheimer's β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 2007, 46:1888-1899.
11. Matharu B., Gibson G., Parsons R., Huckerby T.N., Moore S.A., Cooper L.J., et al. Galantamine inhibits β-amyloid aggregation and cytotoxicity. J. Neurol. Sci. 2009, 280:49-58.
12. Longpre F., Garneau P., Christen Y., Ramassamy C. Protection by EGb 761 against beta-amyloid-induced neurotoxicity involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic. Biol. Med. 2006, 41:1781-1794.
13. Kim W., Kim Y., Min J., Kim D.J., Chang Y.T., Hecht M.H. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide. ACS Chem. Biol. 2006, 1:461-469.
14. Esteras-Chopo A., Pastor M.T., Serrano L., Lopez de la Paz M. New strategy for the generation of specific D-peptide amyloid inhibitors. J. Mol. Biol. 2008, 377:1372-1381.
15. Yazdanparast R., Shaykhalishahi H. Protective effect of a triazine-derivative (AA3E2) on β-amyloid-induced damages in SK-N-MC cells. Toxicol. In Vitro 2009, 23:1277-1283.
16. 2-induced neuroblastoma cell cytotoxicity by a triazine derivative, AA3E2. Eur. J. Pharmacol. 2009, 622:1-6.
17. Bork J.T., Lee J.W., Khersonsky S.M., Moon H.S., Chang Y.T. Novel orthogonal strategy toward solid-phase synthesis of 1, 3, 5-subsituted triazines. Org. Lett. 2003, 5:117-120.
18. Pillot T., Drouet B., Queille S., Labeur C., Vandekerchkhove J., Rosseneu M., et al. The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. J. Neurochem. 1999, 73:1626-1634.
19. Klunk W.E., Jacob R.F., Mason R.P. Quantifying amyloid β-peptide (Aβ) aggregation using the Congo red-Aβ (CR-Aβ) spectrophotometric assay. Anal. Biochem. 1999, 266:66-76.
20. Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A., Boyd M.R. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 1999, 51:2515-2520.
21. LeBel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2', 7' dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 1992, 5:227-231.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
23. Saydam G., Aydin H.H., Sahin F., Selvi N., Oktem G., Terzioglu E., et al. Involvement of protein phosphatase 2A in interferon-alpha-2b-induced apoptosis in K56 human chronic myelogenous leukaemia cells. Leukemia Res. 2003, 27:709-717.
24. Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 1996, 14:33-38.
25. Schuttelkopf A.W., van Aalten D.M. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D: Biol. Crystallogr. 2004, 60:1355-1363.
26. Trott O., Olson A.J. Auto Dock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010, 31:455-461.
27. Harada J., Sugimoto M. Activation of caspase-3 in beta-amyloid-induced apoptosis of cultured rat cortical neurons. Brain Res. 1999, 842:311-323.
28. D.L. Spector, R.D. Godman, L.A. Leinwand, Cells: A Laboratory Manual. Vols. 1-3. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1998.
29. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 2004, 10:18-25.
30. Pratico D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann. N. Y. Acad. Sci. 2008, 1147:70-78.
31. Sultana R., Ravagna A., Mohmmad-Abdul H., Calabrese V., Butterfield D.A. Ferulic acid ethyl ester protects neurons against amyloid beta-peptide (1-42) induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J. Neurochem. 2005, 92:749-758.
32. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999, 38:7609-7616.
33. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-827.
34. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
35. Bucciantini M., Rigacci S., Berti A., Pieri L., Cecchi C., Nosi D., et al. Patterns of cell death triggered in two different cell lines by HypF-N prefibrillar aggregates. FASEB J. 2005, 19:437-439.
36. Suzuki A. Amyloid beta-protein induces necrotic cell death mediated by ICE cascade in PC12 cells. Exp. Cell Res. 1997, 234:507-511.
37. Hetenyi C., Kortvelyesi T., Penke B. Mapping of possible binding sequences of two beta-sheet breaker peptides on beta amyloid peptide of Alzheimer's disease. Bioorg. Med. Chem. 2002, 10:1587-1593.
38. Frederiske P.H., Garland D., Zigler J.S., Piatigorsky J. Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (A beta) in mammalian lense and A beta has toxic effects on lens epithelial cells. J. Biol. Chem. 1996, 271:10169-10174.
39. Misonou H., Morishima-Kawashima M., Ihara Y. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 2000, 39:6951-6959.
40. Shen C., Chen Y., Liu H., Zhang K., Zhang T., Lin A., et al. Hydrogen peroxide promotes Aβ production through JNK-dependent activation of γ-secretase. J. Biol. Chem. 2008, 283:17721-17730.
41. Tong Y., Zhou W., Fung V., Christensen M.A., Qing H., Sun X., Song W. Oxidative stress potentiates BACE1 gene expression and Abeta generation. J. Neural Transm. 2005, 112:455-469.
42. Tamagno E., Guglielmotto M., Aragno M., Borghi R., Autelli R., Giliberto L., et al. Oxidative stress activates a positive feedback between the γ- and β-secretase cleavages of the β-amyloid precursor protein. J. Neurochem. 2008, 104:683-695.